| |
| |
|
| Insider
Information: |
Graf Susan E |
| Relationship: |
Director |
| City: |
Bedminster |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
5,010 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
5,010 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
NPS Pharmaceuticals Inc |
NPSP |
VP,Corp Development & ... |
2015-02-21 |
0 |
2014-06-17 |
0 |
Premium* |
|
|
Finch Therapeutics Group, Inc. |
FNCH |
Director |
2023-06-09 |
5,010 |
2023-06-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
8 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FNCH |
Finch Therapeutics Group,... |
Director |
– • – |
2023-06-09 |
4 |
B |
$0.27 |
$1,353 |
D/D |
5,010 |
5,010 |
2.31 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
VP,Corp Development & Strategy |
• – – |
2015-02-21 |
4 |
D |
$46.00 |
$219,006 |
D/D |
(4,761) |
0 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
VP,Corp Development & Strategy |
• – – |
2015-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,445 |
5,245 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
VP,Corp Development & Strategy |
• – – |
2015-02-12 |
4 |
D |
$45.85 |
$22,191 |
D/D |
(484) |
4,761 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
VP, Corp Development & Strateg |
• – – |
2015-02-10 |
4 |
OE |
$14.90 |
$99,994 |
D/D |
6,711 |
10,511 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
VP, Corp Development & Strateg |
• – – |
2015-02-10 |
4 |
S |
$45.87 |
$307,834 |
D/D |
(6,711) |
3,800 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
VP,Corp Development & Strategy |
• – – |
2014-06-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,788 |
5,788 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
VP,Corp Development & Strategy |
• – – |
2014-06-17 |
4 |
D |
$33.10 |
$65,803 |
D/D |
(1,988) |
3,800 |
0 |
- |
|
8 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
